Segantii Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

Segantii Capital Management’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,000	Closed	-$351K	–	98
2023 Q4	$351K	Hold	50,000	–	–	0.02%	116
2023 Q3	$351K	Hold	50,000	–	–	0.01%	131
2023 Q2	$512K	Hold	50,000	–	–	0.03%	123
2023 Q1	$503K	Hold	50,000	–	–	0.02%	237
2022 Q4	$501K	Hold	50,000	–	–	0.02%	288
2022 Q3	$491K	Hold	50,000	–	–	0.01%	394
2022 Q2	$490	Hold	50,000	–	–	0.01%	371
2022 Q1	$492K	Hold	50,000	–	–	0.01%	369
2021 Q4	$498K	Hold	50,000	–	–	0.02%	336
2021 Q3	$495K	Hold	50,000	–	–	0.02%	298
2021 Q2	$500K	Buy	+50,000	New	+$35.7K	0.01%	327

Other funds holding COCHW

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Segantii Capital Management's COCHW Position: Q1 2024 in Review

Segantii Capital Management sold out of Envoy Medical Warrant (COCHW) in Q1 2024, closing a stake of 50,000 shares — an estimated $351K sold.

Segantii Capital Management first reported a position in COCHW in Q2 2021 and held it in 11 quarters. The position peaked at $512K in Q2 2023. 47 funds tracked by Wall St. Rank hold COCHW as of Q1 2024.

Segantii Capital Management reported no remaining Envoy Medical Warrant position as of Q1 2024 after selling out during the quarter.
Segantii Capital Management sold 50,000 Envoy Medical Warrant shares in Q1 2024, an estimated $351K.
Segantii Capital Management first reported a position in Envoy Medical Warrant in Q2 2021 and held it in 11 quarters.
Segantii Capital Management's Envoy Medical Warrant position peaked at $512K in Q2 2023.
47 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2024.

Based on Segantii Capital Management's 13F filing for Q1 2024, filed 14 May 2024.